Literature DB >> 27143679

Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation.

Hyoung-Mo Yang1, Kiran Khush1, Helen Luikart1, Kozo Okada1, Hong-Seok Lim1, Yuhei Kobayashi1, Yasuhiro Honda1, Alan C Yeung1, Hannah Valantine1, William F Fearon2.   

Abstract

BACKGROUND: The aim of this study is to determine the prognostic value of invasively assessing coronary physiology early after heart transplantation. METHODS AND
RESULTS: Seventy-four cardiac transplant recipients had fractional flow reserve, coronary flow reserve, index of microcirculatory resistance (IMR), and intravascular ultrasound performed down the left anterior descending coronary artery soon after (baseline) and 1 year after heart transplantation. The primary end point was the cumulative survival free of death or retransplantation at a mean follow-up of 4.5±3.5 years. The cumulative event-free survival was significantly lower in patients with a fractional flow reserve <0.90 at baseline (42% versus 79%; P=0.01) or an IMR ≥20 measured 1 year after heart transplantation (39% versus 69%; P=0.03). Patients in whom IMR decreased or did not change from baseline to 1 year had higher event-free survival compared with patients with an increase in IMR (66% versus 36%; P=0.03). Fractional flow reserve <0.90 at baseline (hazard ratio, 0.13; 95% confidence interval, 0.02-0.81; P=0.03), IMR ≥20 at 1 year (hazard ratio, 3.93; 95% confidence interval, 1.08-14.27; P=0.04), and rejection during the first year (hazard ratio, 6.00; 95% confidence interval, 1.56-23.09; P=0.009) were independent predictors of death/retransplantation, whereas intravascular ultrasound parameters were not.
CONCLUSIONS: Invasive measures of coronary physiology (fractional flow reserve and IMR) determined early after heart transplantation are significant predictors of late death or retransplantation.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  heart transplantation; physiology; treatment outcome

Mesh:

Year:  2016        PMID: 27143679     DOI: 10.1161/CIRCULATIONAHA.115.018741

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.

Authors:  Travis B DeSa; Muhannad A Abbasi; Julie A Blaisdell; Kai Lin; Jeremy D Collins; James C Carr; Michael Markl
Journal:  Clin Imaging       Date:  2019-12-19       Impact factor: 1.605

2.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

3.  Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy.

Authors:  Jang Hoon Lee; Kozo Okada; Kiran Khush; Yuhei Kobayashi; Seema Sinha; Helen Luikart; Hannah Valantine; Alan C Yeung; Yasuhiro Honda; William F Fearon
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

4.  Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

Authors:  William F Fearon; Kozo Okada; Jon A Kobashigawa; Yuhei Kobayashi; Helen Luikart; Sean Sana; Tiffany Daun; Steven A Chmura; Seema Sinha; Garett Cohen; Yasuhiro Honda; Michael Pham; David B Lewis; Daniel Bernstein; Alan C Yeung; Hannah A Valantine; Kiran Khush
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

5.  Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

Authors:  Jung-Min Ahn; Frederik M Zimmermann; Satish Arora; Ole-Geir Solberg; Oskar Angerås; Katrine Rolid; Muzammil Rafique; Lars Aaberge; Kristjan Karason; Kozo Okada; Helen Luikart; Kiran K Khush; Yasuhiro Honda; Nico H J Pijls; Sang Eun Lee; Jae-Joong Kim; Seung-Jung Park; Lars Gullestad; William F Fearon
Journal:  Eur Heart J       Date:  2021-12-21       Impact factor: 35.855

6.  Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation.

Authors:  Rushi V Parikh; Kiran Khush; Helen Luikart; Charlotte Sakarovitch; Justin Lee; Manisha Desai; Hannah Valantine; Alan C Yeung; William F Fearon
Journal:  Am J Cardiol       Date:  2018-08-21       Impact factor: 2.778

7.  Cell-Free DNA to Detect Heart Allograft Acute Rejection.

Authors:  Sean Agbor-Enoh; Palak Shah; Ilker Tunc; Steven Hsu; Stuart Russell; Erika Feller; Keyur Shah; Maria E Rodrigo; Samer S Najjar; Hyesik Kong; Mehdi Pirooznia; Ulgen Fideli; Alfiya Bikineyeva; Argit Marishta; Kenneth Bhatti; Yanqin Yang; Cedric Mutebi; Kai Yu; Moon Kyoo Jang; Charles Marboe; Gerald J Berry; Hannah A Valantine
Journal:  Circulation       Date:  2021-01-13       Impact factor: 29.690

Review 8.  Cardiac allograft vasculopathy: current review and future research directions.

Authors:  Jordan S Pober; Sharon Chih; Jon Kobashigawa; Joren C Madsen; George Tellides
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 9.  Evaluation of cardiac allograft vasculopathy by positron emission tomography.

Authors:  Attila Feher; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2021-01-03       Impact factor: 5.952

10.  Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report.

Authors:  Nikhil Narang; Diego Medvedofsky; Kathryn Dryer; Sanjiv J Shah; Charles J Davidson; Amit R Patel; John E A Blair
Journal:  ESC Heart Fail       Date:  2017-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.